PTGX Free Cash Flow Growth
Protagonist Therapeutics Inc · Free Cash Flow Growth
PTGX Free Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported256.27%period ending
PTGX TTM Free Cash Flow YoY % (-105.30% → 256.27%)
Year-over-year change
High-resolution chart · PNG
PTGX free cash flow growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | Free Cash Flow Growth |
|---|---|
| 256.2684% | |
| -134.6883% | |
| -68.4508% | |
| -72.2056% | |
| -83.9293% | |
| 622.5861% | |
| 358.0239% | |
| 291.8354% | |
| 295.902% | |
| 39.0992% | |
| 34.964% | |
| -14.4967% | |
| -9.3796% | |
| 10.7271% | |
| 0.0312% | |
| -3.5101% | |
| -21.8021% | |
| -37.4355% | |
| -49.3606% | |
| -47.2514% | |
| -33.9238% | |
| -106.1486% | |
| -71.6831% | |
| -79.3159% | |
| -96.148% | |
| 19.7689% | |
| 15.7417% | |
| 29.8617% | |
| -647.7459% | |
| -2,890.4954% | |
| -1,673.0817% | |
| -808.9595% | |
| 88.7038% | |
| 95.0773% | |
| 110.5631% | |
| 130.0219% | |
| -77.706% | |
| -97.7181% | |
| -105.2963% |